Antibodies targeting Glycoprotein VI

US11542329B2 · kind B2 · utility

Assignee

• MORPHOSYS AG · DE

Inventors

• Kerstin Uhland · Planegg, DE
• Julia Neugebauer · Munich, DE
• Steffen Runz · Heidelberg, DE

Key dates

• Filing date: May 15, 2019
• Grant date: Jan 3, 2023
• Expiry date: Aug 19, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides antibodies or antibody fragments specific for GPVI. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment or prophylaxis of GPVI related disorders or conditions, such as for example thrombotic or vascular disorders.